We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Must Provide Greater Disclosure of Drug Price Negotiations Due to Legal Setback
Industry Must Provide Greater Disclosure of Drug Price Negotiations Due to Legal Setback
June 9, 2006
The Supreme Court’s refusal to review a case upholding a state fiduciary disclosure law has opened drug company price negotiations up to public scrutiny, which opponents say will undermine competition and raise prices.